Lifetime risk model matched standard 10-year prediction accuracy
Both models scored 0.860 in women and 0.845 in men for distinguishing who developed cardiovascular disease over 10 years.
Our read
Biomarkers- Studied:
- Preprint: cohort study of 3,246,602 adults in the validation cohort, against the existing QRISK4 risk model (Independent replication)
- What changed:
- Prediction accuracy matched QRISK4: both scored 0.860 in women and 0.845 in men for distinguishing who developed cardiovascular disease
- The catch:
- Only 10-year predictions were validated, not lifetime risk estimates
Editor of record: Boris Djordjevic · AgingResearch.News
Adults in an English cohort of 9,976,306 people supplied linked health records for an observational cohort study developing QRISK4-Lifetime. This model estimates the risk of cardiovascular disease, which affects the heart and blood vessels, to age 95. A separate cohort of 3,246,602 people provided validation data.
At 10 years, the model performed similarly to QRISK4, an existing risk model. Predicted risks were close to observed risks. Each risk-selection approach selected 310,648 people: one used a 10-year risk of at least 10%, while the other used lifetime risk to age 95. Among the 262,417 people selected only by lifetime risk, 72.8% were younger than 40 and 79.5% were men.
Why it matters
Cardiovascular prevention spans adulthood. The authors suggest lifetime estimates may complement 10-year estimates in discussions about prevention.
Caveats
The 10-year validation does not establish whether predictions to age 95 are accurate or whether using both time horizons improves prevention outcomes. The work is a preprint and has not been peer-reviewed.
The paper
Queen Mary University of London
medRxiv, Nov 9, 2026, Open access, CC BY-NC-ND, Preprint, not yet peer-reviewed
Comments
Be the first to comment.